Clopidogrel hyporesponsiveness and the FDA boxed warning: Detection and management of patients with genetic polymorphisms

被引：6
|
作者：
Perry, Elizabeth [1 ]
机构：
[1] Univ Louisiana, Monroe Coll Pharm, Shreveport, LA 71103 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2011年 / 68卷 / 06期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PRASUGREL; THROMBOLYSIS; INHIBITION; COMMON;
D O I：
10.2146/ajhp100422
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：529 / 532
页数：4
相关论文
共 39 条
  • [1] The US FDA has added a new boxed warning to Plavix [clopidogrel].
    Reactions Weekly, 2010, 1293 (1) : 2 - 2
  • [2] ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA "Boxed Warning" A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
    Holmes, David R., Jr.
    Dehmer, Gregory J.
    Kaul, Sanjay
    Leifer, Dana
    O'Gara, Patrick T.
    Stein, C. Michael
    CIRCULATION, 2010, 122 (05) : 537 - 557
  • [3] ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA "Boxed Warning" A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
    Holmes, David R., Jr.
    Dehmer, Gregory J.
    Kaul, Sanjay
    Leifer, Dana
    O'Gara, Patrick T.
    Stein, C. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (04) : 321 - 341
  • [4] EFFICACY OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE AFTER PCI CONSIDERING WITH GENETIC POLYMORPHISMS
    Uzokov, J.
    Alyavi, B.
    ATHEROSCLEROSIS, 2020, 315 : E84 - E84
  • [5] GENETIC POLYMORPHISMS AND CARDIOVASCULAR OUTCOMES IN CHINESE PATIENTS UNDERGOING PCI AND TREATED WITH CLOPIDOGREL AND ASPIRIN
    Xu, Ke
    Zhu, Tiantian
    Kong, Deyu
    Zhu, Hui
    Li, Jimin
    Wang, Fei
    Yang, Lu
    Fan, Yuansheng
    Zhang, Jing
    Lu, Yi
    Xu, Lei
    Yang, Mingwen
    Gu, Qian
    Shi, Lu
    Gong, Xiaoxuan
    Chan, Noel C.
    Li, Chunjian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 169 - 169
  • [6] Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin
    Xu, K.
    Ying, L.
    Chen, J.
    Xu, L.
    Li, J.
    Zhu, H.
    Wang, F.
    Yang, L.
    Zhang, J.
    Fan, Y.
    Zhu, T.
    Kong, D.
    Chan, N.
    Li, C.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3395 - 3395
  • [7] Effects of four novel genetic polymorphisms on clopidogrel efficacy in Chinese acute coronary syndromes patients
    Xiao, Fei-Yan
    Liu, Min
    Chen, Bi-Lian
    Cao, Shan
    Fan, Lan
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    Zhang, Wei
    Zhou, Gan
    GENE, 2017, 623 : 63 - 71
  • [8] Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction
    Pandey, Chandra Prakash
    Misra, Ankita
    Negi, Mahendra Pal Singh
    Kanuri, Babu Nageswararao
    Chhonker, Yashpal Singh
    Bhatta, Rabi Shanker
    Narain, Varun Shanker
    Dikshit, Madhu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (01) : 50 - 61
  • [9] Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty
    Diaz-Villamarin, Xando
    Lucia Davila-Fajardo, Cristina
    Javier Martinez-Gonzalez, Luis
    Carmona-Saez, Pedro
    Sanchez-Ramos, Jesus
    Alvarez Cubero, Maria Jesus
    Miguel Salmeron-Febres, Luis
    Cabeza Barrera, Jose
    Fernandez-Quesada, Fidel
    PHARMACOGENOMICS, 2016, 17 (12) : 1327 - 1338
  • [10] Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy
    Xiao Zou
    Xin-li Deng
    Yin-meng Wang
    Jian-hua Li
    Lin Liu
    Xin Huang
    Lu Liu
    Jian Cao
    Li Fan
    International Journal of Clinical Pharmacy, 2020, 42 : 158 - 166
1234